RARE Return on Tangible Equity | ULTRAGENYX PHARMACEUTICAL INC.

ULTRAGENYX PHARMACEUTICAL INC. (RARE) Return on Tangible Equity

2026-06-30: Return Tang Equity 174.89%.
2026-03-31: Return Tang Equity 217.45%.
2025-12-31: Return Tang Equity 463.51%.
2025-09-30: Return Tang Equity 685.44%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	174.89%
2026-03-31	217.45%
2025-12-31	463.51%
2025-09-30	685.44%
2025-06-30	-930.02%
2025-03-31	-1092.51%
2024-12-31	-351.92%
2024-09-30	-210.96%
2024-06-30	-166.93%
2024-03-31	-1047.52%
2023-12-31	-313.98%
2023-09-30	1450.51%
2023-06-30	-1346.70%
2023-03-31	-496.02%
2022-12-31	-255.86%
2022-09-30	-159.76%
2022-06-30	-79.84%
2022-03-31	-62.53%
2021-12-31	-51.70%
2021-09-30	-39.99%
2021-06-30	-37.88%
2021-03-31	-20.16%
2020-12-31	-16.81%
2020-09-30	-41.23%
2020-06-30	-46.15%
2020-03-31	-75.26%
2019-12-31	-66.09%
2019-09-30	-58.10%
2019-06-30	-47.86%
2019-03-31	-38.54%
2018-12-31	-35.01%
2018-09-30	-30.98%
2018-06-30	-27.81%
2018-03-31	-29.97%
2017-12-31	-89.11%
2017-09-30	-79.79%
2017-06-30	-64.59%
2017-03-31	-53.51%
2016-12-31	-51.87%
2016-09-30	-50.41%
2016-06-30	-45.99%
2016-03-31	-36.13%
2015-12-31	-27.42%
2015-09-30	-18.58%
2015-06-30	-26.23%
2015-03-31	-19.80%
2014-12-31	-32.34%
2014-09-30	-27.28%
2014-06-30	-30.68%
2014-03-31	-25.32%
2013-12-31	46.87%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	463.53%
2024-12-31	-351.92%
2023-12-31	-313.98%
2022-12-31	-255.86%
2021-12-31	-51.70%
2020-12-31	-16.81%
2019-12-31	-66.09%
2018-12-31	-35.01%
2017-12-31	-89.11%
2016-12-31	-51.87%
2015-12-31	-27.42%
2014-12-31	-32.34%
2013-12-31	46.87%
2012-12-31	60.39%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
OMEROS CORP (OMER)	United States	$1.456B	5.50
ArriVent BioPharma, Inc. (AVBP)	United States	$1.485B	-10.25
Innoviva, Inc. (INVA)	United States	$1.493B	4.62
Oric Pharmaceuticals, Inc. (ORIC)	United States	$1.367B	-8.00
ANAPTYSBIO, INC (ANAB)	United States	$1.546B	-60.20
Kailera Therapeutics, Inc. (KLRA)	United States	$1.552B
Kardigan, Inc. (KARD)	United States	$1.346B
Tyra Biosciences, Inc. (TYRA)	United States	$1.337B	-12.83
Bicara Therapeutics Inc. (BCAX)	United States	$1.309B	-10.55
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82